METHODS FOR THE REDUCTION OF TRANSFUSION-TRANSMITTED CYTOMEGALOVIRUS-INFECTION - FILTRATION VERSUS THE USE OF SERONEGATIVE DONOR UNITS

被引:60
作者
HILLYER, CD
EMMENS, RK
ZAGONOVARETTI, M
BERKMAN, EM
机构
[1] EMORY UNIV HOSP, SCH MED, DEPT MED, BLOOD BANK, ATLANTA, GA 30322 USA
[2] TUFTS UNIV, SCH MED, DEPT MED, DIV HEMATOL ONCOL, BOSTON, MA 02111 USA
[3] TUFTS UNIV, SCH MED, NEW ENGLAND MED CTR BLOOD BANK, BOSTON, MA 02111 USA
[4] TUFTS UNIV, NEW ENGLAND MED CTR,SCH MED,DEPT MED, DIV HEMATOL ONCOL, BOSTON, MA 02111 USA
[5] TUFTS UNIV NEW ENGLAND MED CTR, BLOOD BANK, DEPT MED, DIV HEMATOL ONCOL, BOSTON, MA 02111 USA
关键词
D O I
10.1046/j.1537-2995.1994.341095026982.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:929 / 934
页数:6
相关论文
共 73 条
[21]   INFECTIONS IN HEART-LUNG TRANSPLANT RECIPIENTS [J].
DUMMER, JS ;
MONTERO, CG ;
GRIFFITH, BP ;
HARDESTY, RL ;
PARADIS, IL ;
HO, M .
TRANSPLANTATION, 1986, 41 (06) :725-729
[22]   MORBIDITY OF CYTOMEGALO-VIRUS INFECTION IN RECIPIENTS OF HEART OR HEART-LUNG TRANSPLANTS WHO RECEIVED CYCLOSPORINE [J].
DUMMER, JS ;
WHITE, LT ;
HO, M ;
GRIFFITH, BP ;
HARDESTY, RL ;
BAHNSON, HT .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06) :1182-1191
[23]   PREVENTION OF TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS-INFECTION IN NEONATAL PATIENTS BY THE REMOVAL OF WHITE CELLS FROM BLOOD [J].
EISENFELD, L ;
SILVER, H ;
MCLAUGHLIN, J ;
KLEVJERANDERSON, P ;
MAYO, D ;
ANDERSON, J ;
HERSON, V ;
KRAUSE, P ;
SAVIDAKIS, J ;
LAZAR, A ;
ROSENKRANTZ, T ;
PISCIOTTO, P .
TRANSFUSION, 1992, 32 (03) :205-209
[24]  
FILIPOVICH AH, 1992, BLOOD, V80, P2656
[25]   THE INCIDENCE AND CONSEQUENCES OF CYTOMEGALOVIRUS TRANSMISSION VIA BLOOD-TRANSFUSION TO LOW-BIRTH-WEIGHT, PREMATURE-INFANTS IN NORTH-EAST SCOTLAND [J].
GALEA, G ;
URBANIAK, SJ .
VOX SANGUINIS, 1992, 62 (04) :200-207
[26]  
GERMENIS A, 1989, ACTA HAEMATOL-BASEL, V82, P57
[27]   PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALO-VIRUS INFECTION IN INFANTS BY BLOOD FILTRATION TO REMOVE LEUKOCYTES [J].
GILBERT, GL ;
HUDSON, IL ;
HAYES, K ;
JAMES, J .
LANCET, 1989, 1 (8649) :1228-1231
[28]  
GLENN J, 1981, REV INFECT DIS, V3, P1151
[29]   EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
MORI, M ;
GLEAVES, CA ;
DUMOND, C ;
CAYS, M ;
EBELING, DF ;
BUHLES, WC ;
DEARMOND, B ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1601-1607
[30]   CYTOMEGALO-VIRUS INFECTION IN A NEONATAL INTENSIVE-CARE UNIT - BLOOD-TRANSFUSION PRACTICES AND INCIDENCE OF INFECTION [J].
GRIFFIN, MP ;
OSHEA, M ;
BRAZY, JE ;
KOEPKE, J ;
KLEIN, D ;
MALLOY, C ;
WILFERT, CM .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1988, 142 (11) :1188-1193